TeraView, the Cambridge UK pioneer in terahertz solutions and technology, has appointed a new chief financial officer as it steps up its global growth strategy.
Lynsey Wilson is a senior level finance executive with over 15 years finance and accounting experience focused on the management of technology-based SME’s.
She joins Teraview from Taptu, where as CFO she was involved in the sale of the company to RSS ad giant Mediafed.
Bruce Anderson, the current chief financial officer, is staying on with TeraView as a senior adviser.
Dr Don Arnone, TeraView CEO said: “Lynsey’s extensive financial experience across a number of innovative technology companies will clearly enhance TeraView’s management team.
“We are excited to welcome Lynsey and she will be a great asset to our future growth strategy. We also wish to take this opportunity to thank Bruce for his commitment to the company and his substantial contribution to its commercial progress over the past several years.”
TeraView was recently cleared by regulators to start trials of a world-first, hand-held breast cancer probe. With support from the Technology Strategy Board (TSB) and in collaboration with surgeons at Guy’s Hospital in London, TeraView has developed the device as part of the world’s first commercial terahertz medical unit.
In January, the company secured $5.5m of investment from a consortium of US, Asian and EU based institutional and corporate investors.
TeraView markets itself as the world’s first company devoted to the application of Terahertz light for spectroscopy and imaging. A spin out from Toshiba and Cambridge University in 2001 and employing circa 25 staff, TeraView has been developing the technology across a number of areas and applications and now has equipment in over 20 countries.
Headquartered in Cambridge, TeraView offers sales and support throughout Europe, North America and the Far East either directly or through a network of distributors.